Josselson alias Dr. Neurotransmitter Nonsense

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure Thyroid Support.

Thyroid Support

Supports

High-quality evidence specifically supporting a broad claim of generic thyroid support is limited. ^[5] One randomized-trial meta-analysis found that long-term exercise-based interventions can improve some thyroid-function measures in people with hypothyroidism, suggesting exercise may be a useful adjunct in selected patients . ^[22] A 2025 systematic review and meta-analysis reported that a gluten-free diet may improve some outcomes in non-celiac Hashimoto’s thyroiditis, but this is a narrow subgroup finding rather than evidence for thyroid support in general . ^[21][23]

Contradicts

The claim is too vague to be directly supported as stated, and there is no major guideline or broad systematic review in the provided index list endorsing unspecified thyroid support for the general population. ^[21] The exercise meta-analysis applies only to hypothyroidism and addresses function, not an all-purpose thyroid-support intervention . ^[22] The gluten-free diet meta-analysis applies only to non-celiac Hashimoto’s thyroiditis and does not establish benefit for people without that condition or for thyroid health broadly . ^[23] The remaining indexed papers are unrelated to thyroid support and do not provide evidentiary backing for the claim.

Mainstream view

Mainstream endocrinology does not recognize a generic thyroid support intervention as an evidence-based medical category. Evidence-based care focuses on diagnosing and treating specific thyroid disorders, correcting identified deficiencies when present, and using standard therapies such as levothyroxine for hypothyroidism or condition-specific management for other thyroid diseases. ^{[1][21][22][4]} Lifestyle measures may be adjunctive in selected patients, but broad thyroid-support claims are not supported as a general medical recommendation.

In their own wordsView sourceArchived copy

“Thyroid Support”

See every doc bro advertising Thyroid disease and Hashimoto

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure Depression.

Depression

Supports

A 2011 narrative review argued that neurotransmitters excreted in urine may have a place in clinical practice as biomarkers of nervous system function and to assess disturbances and monitor treatment efficacy, suggesting some potential for urinary neurotransmitter measurements as biomarkers of nervous system activity rather than direct diagnostic tests.^[6][9] A 2023 worker-screening study reported that urinary neurotransmitters could be a promising indicator to determine underlying mental stress, with levels reported to decrease in individuals with depression; the authors explicitly framed them as potential biomarkers for monitoring mental health conditions and assessing degree of mental stress, not as standalone diagnostic tools.^[8] Historical monoamine research and CSF studies show modest correlations between central monoamine metabolites and certain symptom dimensions (e.g., anxiety/agitation in depression), indicating that neurochemical measures can have some association with mood and anxiety symptoms, but these are research correlations with limited clinical diagnostic utility.^[17][20] Peripheral blood monoamine metabolite levels have been explored as predictors of depressive severity and treatment response, again suggesting some biomarker potential rather than formal diagnostic capability.^[19]

Contradicts

A detailed critique of "spot baseline" urinary monoamine assays concluded that there are no defined applications where such assays can be used to diagnose disease or other states directly, and that no peer‑reviewed original research demonstrates these assays are valid for treatment of individual patients in clinical settings; the marketing model claiming urinary monoamines as biomarkers for ADHD and depression was judged not clinically proven and without scientific foundation.^[11] Major guideline methodology papers emphasize that high‑quality evidence and validated clinical outcomes are required before adopting diagnostic tools; neurotransmitter testing is not mentioned as a diagnostic modality for psychiatric conditions in major guidelines, indicating lack of endorsement and evidentiary support.^[0][4] Historical monoamine hypothesis reviews note that urinary monoamine metabolites (e.g., MHPG) are poor indicators of CNS neurotransmitter turnover, heavily influenced by peripheral sources and factors like physical activity, undermining the premise that peripheral or urinary levels can reliably represent brain neurotransmitter status for diagnostic purposes.^[17] Contemporary expert commentaries and clinical resources state that urinary neurotransmitter testing does not accurately reflect CNS neurotransmitter levels, should not be used to diagnose psychiatric or neurological conditions, and is not supported by major medical authorities for guiding psychotropic treatment or diagnosing depression, anxiety, ADHD, or other behavioral disorders.^[11][13] The available clinical research on urinary neurotransmitters and mental stress frames these measures as potential screening or monitoring biomarkers with acknowledged limitations, explicitly noting that urinary levels may not reflect brain levels, which directly contradicts using them as definitive diagnostic tests for depression, anxiety, insomnia, fatigue, or ADHD.^[8] Overall, there are no randomized trials, large prospective diagnostic accuracy studies, or major psychiatric guidelines validating neurotransmitter testing as a diagnostic tool for the conditions claimed; existing supportive materials are largely methodological, marketing, or exploratory and do not meet the threshold for diagnostic validation.^[11][17]

Mainstream view

Mainstream psychiatry and neurology diagnose depression, anxiety disorders, insomnia, fatigue-related syndromes, and ADHD based on standardized clinical criteria, structured interviews, and validated symptom scales, often complemented by targeted laboratory tests to rule out medical causes, but they do not rely on neurotransmitter testing (urine, saliva, or peripheral blood levels of monoamines) as a diagnostic tool for these conditions.^[11][17] The dominant scientific view is that while neurotransmitters are central to the pathophysiology of mood and behavioral disorders, peripheral or urinary measurements are influenced by multiple systemic and metabolic factors and do not provide a reliable proxy for CNS neurotransmitter function at the individual level.^[17] Major guidelines for psychiatric and neurological disorders focus on clinical assessment and, where applicable, neuropsychological testing or imaging, and do not include commercial neurotransmitter panels as recommended diagnostic tests for depression, anxiety, insomnia, fatigue, or ADHD, reflecting a consensus that such testing lacks sufficient validity and evidence for routine diagnostic use.^[11][4] Neurotransmitter or monoamine metabolite measures may be used in research settings and are being explored as potential biomarkers for stress or treatment response, but current evidence supports only limited, investigational roles rather than formal diagnosis of specific psychiatric conditions.^[8][19][20]

In their own wordsView sourceArchived copy

“Depression”

See every doc bro advertising Depression

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure Behavioral problems (including ADD/ADHD).

Behavioral problems (including ADD/ADHD)

Supports

A 2011 narrative review argued that neurotransmitters excreted in urine may have a place in clinical practice as biomarkers of nervous system function and to assess disturbances and monitor treatment efficacy, suggesting some potential for urinary neurotransmitter measurements as biomarkers of nervous system activity rather than direct diagnostic tests.^[6][9] A 2023 worker-screening study reported that urinary neurotransmitters could be a promising indicator to determine underlying mental stress, with levels reported to decrease in individuals with depression; the authors explicitly framed them as potential biomarkers for monitoring mental health conditions and assessing degree of mental stress, not as standalone diagnostic tools.^[8] Historical monoamine research and CSF studies show modest correlations between central monoamine metabolites and certain symptom dimensions (e.g., anxiety/agitation in depression), indicating that neurochemical measures can have some association with mood and anxiety symptoms, but these are research correlations with limited clinical diagnostic utility.^[17][20] Peripheral blood monoamine metabolite levels have been explored as predictors of depressive severity and treatment response, again suggesting some biomarker potential rather than formal diagnostic capability.^[19]

Contradicts

A detailed critique of "spot baseline" urinary monoamine assays concluded that there are no defined applications where such assays can be used to diagnose disease or other states directly, and that no peer‑reviewed original research demonstrates these assays are valid for treatment of individual patients in clinical settings; the marketing model claiming urinary monoamines as biomarkers for ADHD and depression was judged not clinically proven and without scientific foundation.^[11] Major guideline methodology papers emphasize that high‑quality evidence and validated clinical outcomes are required before adopting diagnostic tools; neurotransmitter testing is not mentioned as a diagnostic modality for psychiatric conditions in major guidelines, indicating lack of endorsement and evidentiary support.^[0][4] Historical monoamine hypothesis reviews note that urinary monoamine metabolites (e.g., MHPG) are poor indicators of CNS neurotransmitter turnover, heavily influenced by peripheral sources and factors like physical activity, undermining the premise that peripheral or urinary levels can reliably represent brain neurotransmitter status for diagnostic purposes.^[17] Contemporary expert commentaries and clinical resources state that urinary neurotransmitter testing does not accurately reflect CNS neurotransmitter levels, should not be used to diagnose psychiatric or neurological conditions, and is not supported by major medical authorities for guiding psychotropic treatment or diagnosing depression, anxiety, ADHD, or other behavioral disorders.^[11][13] The available clinical research on urinary neurotransmitters and mental stress frames these measures as potential screening or monitoring biomarkers with acknowledged limitations, explicitly noting that urinary levels may not reflect brain levels, which directly contradicts using them as definitive diagnostic tests for depression, anxiety, insomnia, fatigue, or ADHD.^[8] Overall, there are no randomized trials, large prospective diagnostic accuracy studies, or major psychiatric guidelines validating neurotransmitter testing as a diagnostic tool for the conditions claimed; existing supportive materials are largely methodological, marketing, or exploratory and do not meet the threshold for diagnostic validation.^[11][17]

Mainstream view

Mainstream psychiatry and neurology diagnose depression, anxiety disorders, insomnia, fatigue-related syndromes, and ADHD based on standardized clinical criteria, structured interviews, and validated symptom scales, often complemented by targeted laboratory tests to rule out medical causes, but they do not rely on neurotransmitter testing (urine, saliva, or peripheral blood levels of monoamines) as a diagnostic tool for these conditions.^[11][17] The dominant scientific view is that while neurotransmitters are central to the pathophysiology of mood and behavioral disorders, peripheral or urinary measurements are influenced by multiple systemic and metabolic factors and do not provide a reliable proxy for CNS neurotransmitter function at the individual level.^[17] Major guidelines for psychiatric and neurological disorders focus on clinical assessment and, where applicable, neuropsychological testing or imaging, and do not include commercial neurotransmitter panels as recommended diagnostic tests for depression, anxiety, insomnia, fatigue, or ADHD, reflecting a consensus that such testing lacks sufficient validity and evidence for routine diagnostic use.^[11][4] Neurotransmitter or monoamine metabolite measures may be used in research settings and are being explored as potential biomarkers for stress or treatment response, but current evidence supports only limited, investigational roles rather than formal diagnosis of specific psychiatric conditions.^[8][19][20]

In their own wordsView sourceArchived copy

“Behavioral problems (including ADD/ADHD)”

See every doc bro advertising ADHD

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure PMS and hormonal imbalance.

PMS and hormonal imbalance

Supports

There is moderate supportive evidence that some complementary and lifestyle interventions used by naturopathic or integrative practitioners can reduce PMS symptom severity, but this support is for specific modalities rather than for generic “naturopathic doctor treatment. ^[25] ” High-quality randomized controlled trials show benefit of non-pharmacologic interventions such as aerobic exercise, diet modification, yoga, progressive muscle relaxation, auriculotherapy, aromatherapy with specific essential oils, and psychological interventions for PMS symptom clusters, including mood and pain. ^[24] Several RCTs and systematic reviews indicate that certain herbs and nutritional supplements (e. ^[26][27] g. , calcium, vitamin B6, chasteberry/Vitex agnus castus, chamomile, selected Iranian herbal preparations, and multi‑nutrient formulations) can improve PMS symptoms, particularly when used in standardized doses under clinical trial conditions. ^[2][4] More recent meta-analyses conclude that herbal medicine and nutritional supplements may be effective and generally safe for PMS when studied in controlled settings, though effects and quality of evidence vary by product and study. ^[5]

Contradicts

There is no high-quality evidence demonstrating that the broad construct of “naturopathic doctor treatment of PMS and hormonal imbalance” as a holistic package is superior to standard medical care or to specific evidence-based interventions, and most trials focus on single modalities rather than comprehensive naturopathic protocols. ^{[1][6][5][24]} Evidence for many popular naturopathic interventions is weak, inconsistent, or based on small, heterogeneous studies that limit firm conclusions; systematic reviews emphasize that no complementary or alternative therapy can be unequivocally recommended as a stand‑alone treatment for PMS on current evidence because of methodological limitations, publication bias, and heterogeneity of the syndrome. ^{[7][25][26][27]} Several widely promoted herbal products and supplements (such as evening primrose oil and some forms of magnesium) show no clear benefit over placebo, and the quality of evidence for many other botanicals or homeopathic remedies remains low. There is also limited or no rigorous evidence that naturopathic approaches can reliably “correct hormonal imbalance” as a disease entity in PMS, beyond modest modulation of symptoms and possible indirect effects via weight loss, stress reduction, or improved lifestyle. Guidelines and mainstream reviews focus on specific agents (e. ^[2] g. , SSRIs, hormonal contraceptives, calcium, vitamin B6, certain botanicals) and lifestyle measures rather than endorsing naturopathy as a distinct therapeutic system.

Mainstream view

The mainstream medical position is that premenstrual syndrome is best managed with a combination of evidence‑based pharmacologic and non‑pharmacologic interventions tailored to symptom severity, not by a specific professional label such as “naturopathic doctor. ^{[1][5][26][27]} ” First‑line or widely accepted options include selective serotonin reuptake inhibitors for moderate to severe PMS or premenstrual dysphoric disorder, combined hormonal contraceptives, and targeted lifestyle strategies such as regular aerobic exercise, sleep optimization, stress management, and dietary adjustments. ^[24][25] Some nutrients (notably calcium and possibly vitamin B6) and selected herbal products (particularly standardized Vitex agnus castus preparations and chamomile) are recognized as having supportive trial data, but they are generally considered adjuncts rather than replacements for established therapies, and clinicians are advised to discuss product quality, dosing, safety, and potential interactions. Major reviews in gynecology and women’s health consider complementary and integrative therapies on an intervention‑by‑intervention basis and do not endorse naturopathy as a unified, guideline‑driven treatment model for PMS or for vaguely defined “hormonal imbalance. ^[6] ” Overall, mainstream practice supports using specific complementary measures that have demonstrated benefit within a shared decision‑making framework, while maintaining skepticism about broad claims that naturopathic treatment as a whole can reliably and comprehensively treat PMS or normalize hormones without robust, system‑level evidence.

In their own wordsView sourceArchived copy

“PMS and hormonal imbalance”

See every doc bro advertising Hormone imbalance and replacement

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to advertise Organic Acid Test (OAT) can diagnose intestinal yeast/bacteria overgrowth, vitamin/mineral deficiencies, oxidative stress, and neurotransmitter levels as a 'comprehensive metabolic snapshot of overall health'. as within their scope of practice.

Organic Acid Test (OAT) can diagnose intestinal yeast/bacteria overgrowth, vitamin/mineral deficiencies, oxidative stress, and neurotransmitter levels as a 'comprehensive metabolic snapshot of overall health'.

Supports

Urinary organic acids testing is an established tool in mainstream medicine for specific, narrow indications, mainly screening for inborn errors of metabolism and certain mitochondrial or metabolic disorders, not for broad functional assessments of health. Large pediatric and metabolic texts describe organic acid analysis as part of the evaluation of unexplained metabolic acidosis, failure to thrive, or suspected inborn metabolic defects, where abnormal organic acids reflect specific enzymatic blocks rather than diffuse gut or wellness states. In intestinal failure and severe malnutrition, metabolic and micronutrient derangements can be reflected in various biochemical tests, but these chapters emphasize standard nutritional, biochemical, and clinical assessment—not OAT—as the basis for diagnosing intestinal pathology or malnutrition. ^[29] Some functional-medicine sources propose that certain urinary organic acids may correlate with gut microbial activity, vitamin cofactor status, oxidative stress, or neurotransmitter metabolism, and these panels are marketed as providing an overview of metabolic function, but these uses are largely extrapolated from basic biochemistry rather than validated in large, prospective diagnostic studies.

Contradicts

Mainstream gastroenterology and nutrition literature do not recognize commercial Organic Acid Tests as diagnostic tools for intestinal yeast or bacterial overgrowth. Evidence-based discussions of small intestinal bacterial overgrowth (SIBO) describe diagnosis by small-bowel aspirate culture or standardized breath tests and do not include urinary organic acid panels as accepted diagnostic methods. ^[28][29] Similarly, in pediatric malnutrition and intestinal failure, core references focus on clinical assessment, anthropometrics, and standard blood-based micronutrient testing for vitamin and mineral deficiencies, not urine organic acid panels. The pediatric and general nutrition literature describes vitamin and mineral deficiency in terms of dietary intake, absorption issues (including bacterial competition for B12 in overgrowth states), and serum or functional biomarkers, not OAT-type panels. There is no high-quality evidence (large RCTs, systematic reviews, or major guidelines) supporting OAT as a reliable test for intestinal yeast/bacterial overgrowth, comprehensive micronutrient status, or clinically relevant oxidative stress and neurotransmitter levels, and several critical reviews note that reference ranges and diagnostic cutoffs for these commercial tests are often not validated in independent peer-reviewed studies. In mainstream practice, urinary neurotransmitter metabolites (such as 5-HIAA or catecholamine metabolites) are used in very specific diagnostic contexts—for example, to evaluate carcinoid tumors or catecholamine-secreting tumors—but not as a generalized assessment of brain neurotransmitter status or overall health, and this limited, disease-focused use is quite different from the broad functional claims of OAT panels.

Mainstream view

The mainstream medical position is that urinary organic acid analysis is a specialized tool used primarily for diagnosing inborn errors of metabolism and certain rare metabolic disorders, generally in hospital or specialized laboratory settings, and is not validated or recommended as a comprehensive metabolic snapshot of overall health. For intestinal yeast or bacterial overgrowth, accepted diagnostic approaches include small-bowel aspirate culture and standardized breath testing; urinary organic acids are not part of guideline-based workups for SIBO, fungal overgrowth, or irritable bowel syndrome. ^[28][29] For vitamin and mineral deficiencies, mainstream practice relies on dietary assessment, clinical examination, and serum or functional blood-based biomarkers (e. g. , serum B12, ferritin, 25-hydroxyvitamin D), occasionally supported by targeted tests based on specific conditions such as bacterial competition for B12 in overgrowth states. Oxidative stress and neurotransmitter status are complex, multi-compartment phenomena for which there is no guideline-endorsed single laboratory test; while certain urinary metabolites can indicate specific pathologies (e. g. , 5-HIAA for serotonin-secreting tumors), these are not used to characterize general neurotransmitter balance or systemic oxidative stress. Major gastroenterology, nutrition, and metabolic guidelines do not recommend commercial OAT panels for routine diagnosis or management of gut disorders, micronutrient status, oxidative stress, or mental health conditions.

In their own wordsView sourceArchived copy

“The Organic Acid Test is a comprehensive metabolic snapshot of overall health with 76 markers. It evaluates intestinal yeast and bacteria and includes markers for vitamins and minerals, oxidative stress, and neurotransmitter levels.”

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to advertise DNA-based Weight Management Program provides 'the only diet and exercise recommendations you will ever need again' based on genotype, eliminating guesswork. as within their scope of practice.

DNA-based Weight Management Program provides 'the only diet and exercise recommendations you will ever need again' based on genotype, eliminating guesswork.

Supports

There is limited evidence that some gene-based lifestyle programs can be implemented for weight management, but not that they provide the only diet and exercise recommendations a person will ever need. ^{[1][5][39][40][43]} A recent randomized controlled trial of a commercial-type gene-based lifestyle program (MyGeneMyDiet) versus standard advice over 12 months found that both groups lost weight, with no meaningful differences in anthropometric or metabolic outcomes, indicating gene-based advice did not clearly outperform conventional guidance. ^[41] Multiple RCTs of genotype-concordant versus discordant macronutrient diets (high-fat vs high-carbohydrate) show that people can lose weight on various diets irrespective of DNA matching. ^[42] Some observational and small interventional studies suggest that genetic variants can have minor modifying effects on weight-loss responses, but these effects are small, inconsistent, and not sufficient to eliminate the need for ongoing adjustment of diet and exercise. A scoping review of nutrigenomics and lifestyle genomics interventions for weight management concluded that effectiveness in real-world clinical practice cannot yet be conclusively determined, which is far from demonstrating a definitive, one-time solution for all future diet and exercise decisions. ^[2]

Contradicts

High-quality evidence from randomized controlled trials and reviews consistently contradicts the idea that DNA-based weight management programs currently provide the only diet and exercise recommendations a person will ever need or that they meaningfully eliminate guesswork. ^{[1][5][39][41]} A large RCT (DIETFITS) in 609 adults found no significant interaction between diet type (low-fat vs low-carbohydrate) and a panel of candidate genotypes; genotype-based matching did not improve 12‑month weight loss compared with standard assignment. ^[42][43] Another RCT using combined genotypes to classify participants as fat- or carbohydrate-responders reported no difference in 12‑week weight loss between genotype-concordant and genotype-discordant diets. An earlier RCT testing multiple obesity-related polymorphisms likewise found that genotype did not have a major impact on weight reduction with low-fat or high-fat hypoenergetic diets and concluded the results did not support revising dietary treatment of obesity based on genotyping. ^[6] A nutrigenetic-guided diet versus standard balanced diet trial similarly showed no significant differences in the proportion achieving clinically meaningful weight loss. The Food4Me European RCT, which compared increasingly personalized dietary advice (including a genetic component) with guideline-based advice, found no additional benefit for weight loss from adding genetic information. ^[40] A 2020 critical scoping review of nutrigenomics and lifestyle genomics interventions for weight management concluded that there is insufficient clinical evidence to determine effectiveness, contradicting claims of definitive, one-time recommendations. Major clinical nutrition and obesity guidelines, as represented by consensus-based methods and GRADE-focused guideline processes , do not recommend routine use of commercial DNA-based weight-loss programs because current evidence is imprecise, heterogeneous, and does not show robust, clinically important benefit. ^[2][3] Existing guidelines on nutrition in specific diseases (e. g. , IBD, parenteral nutrition) focus on clinical status, comorbidities, and patient preferences rather than DNA-based prescriptions, underscoring that genotype is only one of many factors and not a sufficient basis for permanent, exclusive recommendations . ^[4]

Mainstream view

The mainstream medical and scientific position is that, as of now, DNA-based or genotype-guided weight management programs are an experimental adjunct, not a proven replacement for standard, evidence-based diet and exercise counseling. ^{[1][5][39][41][42][43]} High-quality randomized trials show that matching diets to simple genotype panels does not produce substantially greater or more reliable weight loss than conventional, calorie-restricted diets without genetic tailoring. Genetic variants may have small, context-dependent effects on weight-loss response, but these effects are not large or consistent enough to justify claims of delivering the only diet and exercise plan a person will ever need. Current obesity and nutrition guidelines, developed using GRADE and other consensus methods , emphasize personalized care based on clinical factors, comorbidities, preferences, and ongoing monitoring, not on commercial nutrigenetic algorithms. ^{[2][3][4][40]} Mainstream experts view consumer DNA-based weight-loss programs as promising research areas but do not endorse them as standalone, definitive solutions, and they still require iterative adjustment, behavioral support, and consideration of environmental, psychological, and medical factors. Therefore, the claim that such a program eliminates guesswork and provides once-and-for-all recommendations goes beyond and conflicts with the current evidence base and guideline-driven practice. ^[6]

In their own wordsView sourceArchived copy

“This weight management program takes your unique genetic makeup into account and provides you with diet and exercise strategies that are tailored to your genotype. This is not guesswork, one-size-fits-all or a fad diet of any kind – these are the only diet and exercise recommendations you will ever need again, because they are based on your DNA.”

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to advertise Genetics-Based Healthy Aging Program provides nutrient, food, activity, and lifestyle recommendations to keep you looking and feeling young longer based on genetic predisposition. as within their scope of practice.

Genetics-Based Healthy Aging Program provides nutrient, food, activity, and lifestyle recommendations to keep you looking and feeling young longer based on genetic predisposition.

Supports

High-quality evidence shows that providing gene-based dietary advice can modestly improve certain health behaviors compared with generic advice, particularly in specific nutrients or in weight-management contexts. ^[1][5] Several randomized controlled trials of nutrigenomics-based counseling report greater long-term changes in sodium intake and some dietary components when advice is tailored to genetic variants compared with standard recommendations, suggesting that genetic information can influence nutrition-related behavior change and perceived usefulness of advice. ^[4][44][46] Separately, there is strong guideline-level evidence that nutrition, physical activity, and lifestyle modification are central to cardiometabolic health and thus indirectly to healthy aging trajectories, even though these guidelines do not base their recommendations on genetic testing. ^[2][3] More broadly, the field of personalized nutrition and lifestyle interventions recognizes that genetic variants can modulate responses to diet and physical activity, supporting the plausibility that genotype-informed programs might refine risk reduction strategies over the life course, but this remains mostly theoretical and focused on disease risk rather than visible or subjective “youthfulness. ^[45][40] ”

Contradicts

Systematic reviews and expert commentaries in personalized, gene-based nutrition consistently conclude that robust clinical evidence is lacking for broad claims that genetic testing can meaningfully enhance long-term health outcomes beyond conventional lifestyle counseling. ^{[3][4][44][45][46]} They emphasize that most nutrigenetic recommendations are based on limited or inconsistent data, and that proven benefit is confined to narrow gene–nutrient interactions, not global healthy aging or longevity. Large randomized trials of genotype-guided diets (e. g. , matching macronutrient composition to purported fat- vs carbohydrate-responsive genotypes) have found no significant differences in weight loss or major metabolic outcomes compared with non-genotype-based diets, which directly contradicts strong claims that genetic tailoring substantially improves real-world health results. Other RCTs of genetics-based personalized nutrition show either small, specific effects (such as sodium reduction in certain ACE genotypes) or no added benefit over population-based advice for overall diet quality, health markers, or physical activity, indicating that the evidence for broad anti-aging effects is weak. ^[5][40] No major clinical guidelines in cardiology, nutrition, neurology, or general preventive medicine currently recommend consumer genetic-based lifestyle programs as a proven means to slow aging, extend youthfulness, or improve long-term outcomes beyond established risk-factor management; instead, they focus on evidence-based lifestyle interventions (diet quality, physical activity, smoking cessation, blood pressure and lipid control) without requiring genetic testing. ^[1][2][7]

Mainstream view

The mainstream medical and scientific view is that healthy aging is best supported by well-established lifestyle factors—high-quality diet patterns, regular physical activity, adequate sleep, avoidance of tobacco, moderation of alcohol, and rigorous management of cardiovascular and metabolic risk—implemented according to guideline-driven care rather than consumer genetics-based programs. ^{[1][6][5][40]} Genetics is recognized as one contributor to disease risk and aging biology, and there is growing research in nutrigenomics and precision health, but current high-quality evidence does not support claims that commercial genetics-based programs can reliably keep people “looking and feeling young longer” in a broad or clinically meaningful way. Major guidelines in hypertension, clinical nutrition, and related areas do not endorse routine gene-based lifestyle or nutrition testing as a standard of care for healthy aging, instead recommending population-level interventions applicable regardless of genotype, with genetic information occasionally relevant in specific disease contexts. ^{[2][3][4][44][45][46]} Overall, the consensus is that while gene-informed advice may modestly enhance motivation or fine-tune certain recommendations, its added value over conventional evidence-based lifestyle counseling for general healthy aging and youthfulness has not been demonstrated, and marketing claims that such programs can substantially slow aging or maintain youthful appearance are considered unproven.

In their own wordsView sourceArchived copy

“An innovative healthy aging program that utilizes your genetic profile to provide nutrient, food, activity and lifestyle recommendations to keep you looking and feeling young longer.”

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure Blood Sugar Support.

Blood Sugar Support

Supports

The general concept of “blood sugar support” is consistent with established guideline-driven management of hyperglycemia: major societies recommend structured lifestyle changes, diet patterns, and pharmacologic therapy to maintain glucose in target ranges and reduce complications. ^[1][47] Dietary patterns such as the DASH diet have demonstrated beneficial effects on cardiometabolic outcomes, including improved insulin sensitivity and reduced risk of type 2 diabetes, which indirectly supports the idea that evidence-based nutrition can help control blood sugar. ^[49][5] Cinnamon supplementation shows modest, statistically significant improvements in fasting plasma glucose and HbA1c in type 2 diabetes in an updated systematic review and dose–response meta‑analysis of randomized controlled trials, suggesting that some specific supplements can have small supportive effects on glycemic control. ^[48][50] Evidence syntheses on nutrition in conditions like PCOS also support that targeted dietary interventions can improve metabolic and endocrine outcomes, including insulin resistance and glucose metabolism, reinforcing that diet is a legitimate tool for blood sugar management.

Contradicts

High‑quality guidelines for hyperglycemia in hospitalized adults focus on insulin and established pharmacologic agents, not generic “blood sugar support” supplements, and do not recommend over‑the‑counter products as primary therapy. ^[5] The cinnamon meta‑analysis reports only modest effect sizes with substantial heterogeneity and variable trial quality, indicating that while cinnamon may slightly improve glycemic markers, it is not a replacement for standard diabetes treatment and its benefits are limited. ^[48][50] Umbrella reviews of nutrition-related interventions for cardiometabolic disease and PCOS emphasize structured dietary patterns and lifestyle changes, not vague supplement-based “support,” and often highlight that evidence for single-nutrient or proprietary products is weak, inconsistent, or low-certainty. ^[1][49] Major clinical nutrition guidelines in chronic disease settings (e. ^[2][3] g. , ESPEN, ASPEN-FELANPE) stress comprehensive medical nutrition therapy integrated with guideline-based medical care, and do not endorse non-specified “blood sugar support” products as stand-alone strategies. ^[47] Overall, where supplements are studied, the magnitude of benefit tends to be small, evidence quality mixed, and long-term outcome data limited, which contradicts any strong claims that generic “blood sugar support” products meaningfully prevent or treat diabetes on their own.

Mainstream view

The mainstream medical position is that blood sugar control should be achieved primarily through evidence-based lifestyle modification, structured dietary patterns, and guideline-directed pharmacologic therapy tailored to individual risk and disease severity. ^{[1][3][49][5]} Major guidelines for hyperglycemia and diabetes management do not recommend non-specific “blood sugar support” supplements as core therapy; they may be considered adjuncts at best, and only when supported by high-quality data. ^[47][2] Nutritional approaches such as DASH-style diets, weight management, and reduction of refined carbohydrates are accepted components of glycemic management, with stronger evidence and clearer mechanisms than most proprietary supplement formulations. Specific supplements like cinnamon may offer small additional improvements in glycemic markers in type 2 diabetes, but current evidence is heterogeneous and of modest certainty, and these products are not viewed as substitutes for standard care. ^[48] Clinicians generally advise patients to focus on proven diet and medication strategies while being cautious about unregulated “blood sugar support” products whose composition, dosing, and clinical efficacy are not rigorously established.

In their own wordsView sourceArchived copy

“Blood Sugar Support”

See every doc bro advertising Diabetes and blood sugar

Josselson is not approved to offer Detoxification within a Naturopathic Doctor scope of practice under New Jersey Board of Naturopathic Medicine.

Detoxification

Supports

There is limited clinical evidence that some nutrition-based or lifestyle interventions marketed as detox may influence biomarkers of metabolic detoxification or subjective well‑being, but these are generally small pilot trials and do not validate broad naturopathic detoxification as a medical treatment. A pilot, non‑controlled 7‑day detox program in healthy adults showed improved subjective symptom scores and modest changes in liver detoxification measures, suggesting short‑term improvement in well‑being and hepatic clearance capacity, but without a control group this cannot establish efficacy or causality.^[6] A randomized, single‑blind, placebo‑controlled trial of a plant‑based “metabolic detoxification” supplement over 28 days reported reductions in blood toxic metals and some urine biomarkers, along with improved fatigue and sleep scores; however, sample size was small and the intervention was essentially a nutritional product rather than a comprehensive naturopathic detox program.^[12] A three‑arm randomized clinical trial of a plant‑based “detox” diet (Wellnessup) versus a calorie‑restricted diet and usual diet found that the detox diet modestly reduced several toxic trace elements in hair and improved anthropometric measures, but it did not outperform standard calorie restriction for fat loss, again indicating some measurable changes but not strong superiority over conventional dietary measures.^[23] Systematic and narrative reviews of “detox diets” and detoxification‑oriented foods conclude that a few small studies show changes in liver enzymes, pollutant biomarkers, or heavy metals with specific dietary protocols, but methodologies are often weak, sample sizes small, and no robust randomized trials of commercial or naturopathic detox programs exist, so any support is narrow and preliminary rather than generalizable to routine naturopathic detoxification as a treatment.^{[8][9][20][16][19]}

Contradicts

Evidence reviews of detox diets and detoxification practices consistently report that the overall clinical evidence base is very limited, methodologically weak, and insufficient to support broad health claims made by the detox industry, including naturopathic detox programs.^[8][9] A systematic review of colonic cleansing—a common component of many naturopathic detox regimens—found no methodologically rigorous controlled trials demonstrating benefit for general health promotion and documented multiple adverse case reports, concluding that colonic cleansing for health promotion is not supported and cannot be recommended.^[7] Objective assessment of ionic footbaths, another popular detox modality in holistic and naturopathic settings, found no specific induction of toxic element release through the feet or changes in urine, hair, or water that would support detox claims, directly contradicting marketing claims that such devices remove toxins from the body.^[11] Major evidence‑based clinical guidelines for conditions such as hypertension, inflammatory bowel disease, tension‑type headache, or indications for parenteral nutrition do not recommend naturopathic detoxification as a standard or adjunctive treatment, and instead rely on pharmacologic therapy, lifestyle modification, and evidence‑based nutrition approaches.^{[0][1][2][3][4]} Reviews of detox diets emphasize the absence of high‑quality randomized controlled trials assessing real‑world commercial or naturopathic detox programs, meaning that strong claims about disease prevention, cure, or systemic toxin removal are unsupported by rigorous evidence and often conflict with established understanding of endogenous hepatic and renal detoxification.^[8][9]

Mainstream view

Mainstream medicine recognizes that detoxification of xenobiotics and endogenous metabolites is handled primarily by the liver, kidneys, gastrointestinal tract, and lungs through well‑characterized metabolic and excretory pathways, and that in otherwise healthy individuals these systems generally do not require enhancement via commercial or naturopathic “detox” programs. Major evidence‑based guidelines for common diseases focus on validated pharmacologic treatment, lifestyle changes (such as diet, exercise, and smoking cessation), and, when indicated, clinical nutrition support or procedures like blood transfusion, but they do not endorse naturopathic detoxification protocols as standard care or as evidence‑based adjuncts.^{[0][1][2][3][4][7]} Nutritional and toxicology literature acknowledges that specific foods, phytochemicals, or probiotics can modulate metabolic detoxification pathways or heavy‑metal kinetics, but these effects are studied in narrowly defined contexts with carefully controlled interventions and are not extrapolated into broad recommendations for branded or generalized detox programs.^{[9][13][16][20]} Mainstream scientific reviews of detox diets and related practices conclude that the evidence is insufficient, that many interventions lack rigorous safety and efficacy data, and that routine use of such naturopathic detox treatments for general health, chronic disease management, or systemic toxin removal is not supported and should not replace evidence‑based medical care.^[8][7][11]

In their own wordsView sourceArchived copy

“Detoxification”

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure Inflammation.

Inflammation

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Inflammation”

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to advertise Sinus congestion, postnasal drip, asthma as within their scope of practice.

Sinus congestion, postnasal drip, asthma

Supports

There is moderate evidence that some complementary and integrative treatments (herbal medicines, homeopathy, yoga, naturopathy-style lifestyle elements) can improve symptoms of chronic rhinosinusitis and asthma when used alongside conventional care, but this evidence does not specifically validate “naturopathic doctor treatment” as a comprehensive alternative therapy for sinus congestion, postnasal drip, or asthma. A controlled double‑blind trial in sinusitis found that several homeopathic combinations did not outperform placebo, but all groups (including placebo) showed high recovery rates, suggesting at most a non‑specific or placebo-related benefit rather than strong specific efficacy.^[9] A systematic review of herbal medicines for rhinosinusitis identified randomized trials of products such as Sinupret and bromelain, with some positive adjunctive effects, but concluded that evidence is limited, particularly for chronic rhinosinusitis, and that findings require replication.^[16] A more recent systematic review and network meta‑analysis of herbal medicines for rhinosinusitis found low‑certainty evidence that certain herbal products (e.g., Origanum vulgare, Pimpinella anisum-based drops) can improve symptom scores and quality of life in chronic rhinosinusitis populations compared with conventional treatment alone or placebo, again mainly as adjuncts.^[11][18][21] Another systematic review of randomized trials of herbal medicine in chronic rhinosinusitis reported that several medicinal plant preparations may be effective, with no serious adverse reactions, but emphasized that only a small number of trials and heterogeneous methods limit the strength of conclusions.^[14] For asthma, there is emerging but still limited evidence that some plant-based therapies and related approaches can improve symptoms or lung function in addition to standard care; a review of phytotherapy and anthroposophic medicine reported beneficial effects of several plants (e.g., Nigella sativa) on asthma symptoms, pulmonary function, and immunologic parameters, but based on a small set of studies.^[17] An RCT of individualized homeopathy added to usual care in adult bronchial asthma found improved spirometry, eosinophil counts, IgE levels, and symptom severity versus usual care plus placebo, suggesting potential adjunctive benefit in that specific context.^[13] An older matched study of “naturopathy and yoga” in bronchial asthma reported clinical improvement, but its design and age limit its evidentiary weight relative to contemporary RCTs and guidelines.^[19] Overall, high‑quality evidence supports the idea that certain specific herbal or complementary interventions, when carefully selected and used alongside guideline‑based medical therapy, can offer modest symptom relief in chronic rhinosinusitis and asthma, but this does not equate to broad support for naturopathic doctor management as a stand‑alone treatment.

Contradicts

The strongest contradiction to broad claims of efficacy comes from the overall weakness, inconsistency, and low certainty of the complementary medicine evidence base, and from guideline frameworks that prioritize conventional, evidence‑based therapies over naturopathic or alternative regimens. A controlled randomized double‑blind trial in sinusitis showed no meaningful difference between several homeopathic combinations and placebo, indicating that these commonly used naturopathic-style remedies did not demonstrate specific therapeutic efficacy in sinusitis beyond placebo effects.^[9] Complementary and integrative treatments reviews for rhinosinusitis note that data for Chinese medicine, homeopathy, and liposomal therapy are inconclusive due to methodological flaws, small sample sizes, and high risk of bias, reinforcing that current evidence for these modalities is weak and insufficient to recommend them as primary therapy.^[12][20] Systematic reviews of herbal medicines for rhinosinusitis and chronic rhinosinusitis emphasize that although some trials report benefit, the overall quality of evidence is moderate to low, with unclear risk of bias and limited generalizability; authors explicitly state that evidence for herbal medicines is limited, particularly for chronic disease, and that findings require independent replication before strong clinical recommendations can be made.^{[14][16][18][21]} For asthma, mainstream guidelines and high‑quality evidence focus on inhaled corticosteroids, bronchodilators, and biologics; complementary phytotherapy trials are few, often small, and not sufficient to support replacing guideline‑recommended therapies with naturopathic approaches alone.^[17] Major evidence‑based guideline frameworks (e.g., those employing GRADE methodology) underscore the need for high‑quality randomized trials and precise effect estimates for therapeutic recommendations, and the naturopathic treatments in question generally do not meet these standards.^[6] Taken together, current evidence contradicts any strong claim that naturopathic doctor treatment, as a stand‑alone or primary approach, is reliably

In their own wordsView sourceArchived copy

“Sinus congestion, postnasal drip, asthma”

See every doc bro advertising Allergies, asthma and food sensitivities

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure Chronic ear infections.

Chronic ear infections

Supports

High‑quality evidence for naturopathic or other complementary/alternative medicine (CAM) as a primary treatment for chronic ear infections (chronic otitis media with effusion or chronic suppurative otitis media) is very limited, and there are no major RCTs or meta‑analyses showing that naturopathic care can cure or definitively control chronic disease. ^[59][62] Some randomized trials in acute otitis media in children have tested naturopathic or herbal ear drops; these show that herbal/naturopathic drops can reduce ear pain similarly to conventional anesthetic drops over a few days, but these studies address acute pain management rather than chronic infection, hearing outcomes, or long‑term control. Systematic reviews of herbal medicines for otitis media with effusion and acute otitis media report some signal of symptom improvement, but overall rate the evidence as poor quality and inconclusive, with small, heterogeneous trials and high risk of bias. ^{[6][5][60][61]} A broader review of CAM options for otitis media concludes that, despite popularity, CAM therapies are not considered evidence‑based treatments in the medical community because robust, consistent clinical data are lacking. ^[1][2]

Contradicts

Up‑to‑date narrative and guideline‑style reviews of chronic suppurative otitis media emphasize that the optimal evidence‑based treatment for persistent ear discharge is topical antibiotics, with antiseptics as an alternative in resource‑limited settings, and surgery (e. ^{[1][6][59][62]} g. , tympanoplasty, mastoid surgery) for persistent disease; they do not recommend naturopathic or other CAM therapies as curative or primary treatments for chronic ear infections. These reviews highlight that chronic otitis media is a significant cause of preventable hearing loss and sometimes intracranial complications, underscoring the importance of well‑studied antimicrobial and surgical strategies rather than unproven alternatives. Systematic reviews of herbal medicines for otitis media with effusion and for acute otitis media explicitly conclude that, despite some indications of benefit, the overall evidence is of poor quality and efficacy remains inconclusive; this contradicts any strong claim that naturopathic or herbal therapies are established effective treatments for otitis media. ^[5][60][61] A review focused on CAM for pediatric otitis media notes that, among many CAM modalities, only xylitol has reasonably good trial support for prevention of acute episodes; most other CAM approaches (including herbal mixtures, homeopathy, osteopathic manipulation) either show no benefit, possible harm, or remain unproven, which again fails to support strong therapeutic claims for naturopathic management of chronic ear disease. Overall, major otology and pediatric guidelines and reviews do not list naturopathic medicine as a standard, recommended treatment for chronic otitis media; instead, they emphasize watchful waiting, appropriate antibiotics, tympanostomy tubes, and surgery as indicated, indicating that any claim of established naturopathic efficacy is not aligned with current evidence. ^[2][4]

Mainstream view

Mainstream medical and otolaryngology practice regards chronic ear infections (chronic otitis media with effusion and chronic suppurative otitis media) as conditions that should be managed with evidence‑based interventions: accurate diagnosis, risk‑factor management, topical or systemic antibiotics when indicated, tympanostomy tubes for persistent effusion with hearing loss, and surgical repair/mastoid surgery for chronic suppurative disease or cholesteatoma. ^[1][4][59] Complementary or naturopathic therapies may be used by families as adjuncts for symptom relief, but they are not considered proven disease‑modifying treatments for chronic ear infections and are not recommended as replacements for guideline‑based care. ^[3][62] Systematic reviews of herbal and other CAM therapies for otitis media consistently describe the evidence as weak, heterogeneous, and at high risk of bias, leading to the mainstream position that these modalities should, at most, be considered experimental or adjunctive, and that clinicians should counsel families about the current evidence limitations and the risks of delaying effective conventional treatment. ^{[6][5][60][61]}

In their own wordsView sourceArchived copy

“Chronic ear infections”

See every doc bro advertising Ear infections

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure Skin conditions such as eczema.

Skin conditions such as eczema

Supports

There is some limited evidence that certain complementary and alternative modalities sometimes used by naturopathic practitioners can improve eczema or atopic dermatitis outcomes, but this evidence is generally small-scale and heterogeneous. A randomized clinical trial of yoga and naturopathy interventions for atopic dermatitis reported improvements in standardized severity scores (EASI and SCORAD) after 4 weeks, suggesting potential benefit of a multimodal yoga–naturopathy program, though details on blinding and controls are limited and the study is not widely replicated. ^[2][66] Several randomized controlled trials have evaluated specific herbal or botanical preparations for eczema (for example, botanical combination creams, Sambucus ebulus L. ^[65] for hand eczema, and traditional Chinese herbal decoctions), with some demonstrating reductions in eczema severity indices, itching, and recurrence rates comparable to or better than standard comparators such as hydrocortisone or other conventional products. Systematic and narrative reviews of complementary and alternative medicine in atopic eczema conclude that there is at least some level I evidence supporting selected modalities such as acupuncture/acupressure, certain stress‑reducing techniques (hypnosis, massage, biofeedback), balneotherapy, specific herbal preparations and botanical oils, oral evening primrose oil, vitamin D supplementation, and topical vitamin B12, although the strength of evidence is generally modest and methodologic quality variable. ^[5][63] Major dermatology guidelines and evidence summaries acknowledge that some complementary interventions (e. g. , probiotics in prevention, psychological and educational interventions, selected supplements or oils) may have modest benefit in atopic dermatitis, but they emphasize that these should be adjunctive to, not replacements for, conventional therapy and that efficacy, safety, and optimal dosing remain uncertain. ^[7] Overall, the available evidence supports a narrow claim that certain individual complementary or herbal treatments sometimes used by naturopathic doctors can improve eczema severity in specific contexts, but this does not amount to strong evidence that naturopathic doctor management as a whole is an established or superior treatment for eczema. ^[1][6][64]

Contradicts

High‑quality evidence specifically supporting naturopathic doctor–led treatment programs for eczema is sparse, and most trials evaluate single complementary modalities rather than a comprehensive naturopathic approach. Systematic reviews of homeopathy for eczema and controlled trials of individualized homeopathic remedies (a modality frequently included in naturopathic care) consistently fail to demonstrate efficacy beyond placebo or find, at best, equivocal and preliminary results; overall, these reviews conclude there is no convincing evidence that homeopathy is an effective treatment for eczema. ^[64][65][66] A systematic review of topical herbal medicines for atopic eczema finds insufficient evidence of efficacy for any single topical herbal extract, with many studies being small, uncontrolled, or methodologically weak, indicating that current data do not robustly support routine use of these products. ^[63] A broad review of complementary and alternative medicine for atopic dermatitis states that although some interventions show promise, the overall evidence base is limited, heterogeneous, and often underpowered, and it explicitly notes a lack of convincing evidence for homeopathy and several other commonly promoted therapies. Major clinical guidelines for eczema and atopic dermatitis emphasize emollients, topical corticosteroids, calcineurin inhibitors, targeted immunomodulators, and trigger avoidance as the core of evidence‑based management; complementary or naturopathic treatments are generally not recommended as primary therapy and are discussed, if at all, as experimental or adjunctive options pending stronger evidence. ^[1][2][5][7] Taken together, current peer‑reviewed evidence does not substantiate broad claims that naturopathic doctor treatment is an established, reliably effective, or guideline‑endorsed primary approach for eczema, and some commonly used naturopathic modalities (especially homeopathy) are specifically judged ineffective or unproven. ^[6]

Mainstream view

The mainstream medical position is that eczema (atopic dermatitis and related chronic inflammatory skin conditions) should be managed primarily with evidence‑based conventional therapies: regular use of emollients, appropriate potency topical corticosteroids, topical calcineurin inhibitors, targeted biologic or small‑molecule immunomodulators when indicated, infection management when clearly necessary, and comprehensive education on trigger avoidance and skin care. ^[1][4][63] Authoritative guidelines and reviews recognize that certain complementary or integrative approaches (such as specific psychological and educational interventions, some probiotic strategies in prevention, carefully selected herbal or botanical preparations, acupuncture, and stress‑reduction techniques) may offer adjunctive benefit for some patients, but they emphasize that these are not substitutes for standard care, require individual risk–benefit assessment, and should be based on the best available evidence. ^[2][5] Homeopathy and many generalized naturopathic regimens are not endorsed in mainstream guidelines as effective treatments for eczema due to a lack of consistent high‑quality ^[65]

In their own wordsView sourceArchived copy

“Skin conditions such as eczema”

See every doc bro advertising Skin conditions

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure GI issues such as gas, bloating, diarrhea.

GI issues such as gas, bloating, diarrhea

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“GI issues such as gas, bloating, diarrhea”

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure Stress.

Stress

Supports

Urinary organic acids testing is an established tool in mainstream medicine for specific, narrow indications, mainly screening for inborn errors of metabolism and certain mitochondrial or metabolic disorders, not for broad functional assessments of health. Large pediatric and metabolic texts describe organic acid analysis as part of the evaluation of unexplained metabolic acidosis, failure to thrive, or suspected inborn metabolic defects, where abnormal organic acids reflect specific enzymatic blocks rather than diffuse gut or wellness states. In intestinal failure and severe malnutrition, metabolic and micronutrient derangements can be reflected in various biochemical tests, but these chapters emphasize standard nutritional, biochemical, and clinical assessment—not OAT—as the basis for diagnosing intestinal pathology or malnutrition. ^[29] Some functional-medicine sources propose that certain urinary organic acids may correlate with gut microbial activity, vitamin cofactor status, oxidative stress, or neurotransmitter metabolism, and these panels are marketed as providing an overview of metabolic function, but these uses are largely extrapolated from basic biochemistry rather than validated in large, prospective diagnostic studies.

Contradicts

Mainstream gastroenterology and nutrition literature do not recognize commercial Organic Acid Tests as diagnostic tools for intestinal yeast or bacterial overgrowth. Evidence-based discussions of small intestinal bacterial overgrowth (SIBO) describe diagnosis by small-bowel aspirate culture or standardized breath tests and do not include urinary organic acid panels as accepted diagnostic methods. ^[28][29] Similarly, in pediatric malnutrition and intestinal failure, core references focus on clinical assessment, anthropometrics, and standard blood-based micronutrient testing for vitamin and mineral deficiencies, not urine organic acid panels. The pediatric and general nutrition literature describes vitamin and mineral deficiency in terms of dietary intake, absorption issues (including bacterial competition for B12 in overgrowth states), and serum or functional biomarkers, not OAT-type panels. There is no high-quality evidence (large RCTs, systematic reviews, or major guidelines) supporting OAT as a reliable test for intestinal yeast/bacterial overgrowth, comprehensive micronutrient status, or clinically relevant oxidative stress and neurotransmitter levels, and several critical reviews note that reference ranges and diagnostic cutoffs for these commercial tests are often not validated in independent peer-reviewed studies. In mainstream practice, urinary neurotransmitter metabolites (such as 5-HIAA or catecholamine metabolites) are used in very specific diagnostic contexts—for example, to evaluate carcinoid tumors or catecholamine-secreting tumors—but not as a generalized assessment of brain neurotransmitter status or overall health, and this limited, disease-focused use is quite different from the broad functional claims of OAT panels.

Mainstream view

The mainstream medical position is that urinary organic acid analysis is a specialized tool used primarily for diagnosing inborn errors of metabolism and certain rare metabolic disorders, generally in hospital or specialized laboratory settings, and is not validated or recommended as a comprehensive metabolic snapshot of overall health. For intestinal yeast or bacterial overgrowth, accepted diagnostic approaches include small-bowel aspirate culture and standardized breath testing; urinary organic acids are not part of guideline-based workups for SIBO, fungal overgrowth, or irritable bowel syndrome. ^[28][29] For vitamin and mineral deficiencies, mainstream practice relies on dietary assessment, clinical examination, and serum or functional blood-based biomarkers (e. g. , serum B12, ferritin, 25-hydroxyvitamin D), occasionally supported by targeted tests based on specific conditions such as bacterial competition for B12 in overgrowth states. Oxidative stress and neurotransmitter status are complex, multi-compartment phenomena for which there is no guideline-endorsed single laboratory test; while certain urinary metabolites can indicate specific pathologies (e. g. , 5-HIAA for serotonin-secreting tumors), these are not used to characterize general neurotransmitter balance or systemic oxidative stress. Major gastroenterology, nutrition, and metabolic guidelines do not recommend commercial OAT panels for routine diagnosis or management of gut disorders, micronutrient status, oxidative stress, or mental health conditions.

In their own wordsView sourceArchived copy

“Stress”

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure Poor diet.

Poor diet

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Poor diet”

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure Toxic chemicals.

Toxic chemicals

Supports

The influencer’s very broad claim about “toxic chemicals” is only meaningfully supported when interpreted as: certain environmental and occupational chemical exposures are associated with adverse health outcomes, including congenital anomalies and other diseases. ^[4] An umbrella review of environmental and genetic risk factors for congenital anomalies identified maternal exposure to environmental toxic chemicals (including solvents, pesticides, and heavy metals) as one of several non‑genetic risk factors; a pooled analysis of six studies reported a modest association between toxic chemicals and congenital anomalies (pooled OR about 1. ^[67][69][71] 3, 95% CI 1. 06–1. 63). This same umbrella review concluded that maternal exposure to environmental toxic chemicals and air pollution is among multiple contributors to increased risk of congenital anomalies, alongside smoking, diabetes, obesity, and drug intake. A systematic review and meta‑analysis focusing on mothers occupationally exposed to solvents found statistically significant associations between such solvent exposure and neural tube defects, congenital heart defects, and orofacial clefts in offspring, supporting the idea that specific workplace chemical exposures can increase teratogenic risk. ^[68][70] Additional systematic and umbrella reviews (outside the provided index list) show harmful associations between major classes of endocrine‑disrupting and plastic‑associated chemicals (e. g. , bisphenol A, phthalates, PCBs, PBDEs, some PFAS) and a range of outcomes including reproductive, metabolic, cardiovascular, neurodevelopmental, and perinatal effects, reinforcing that some chemicals at real‑world exposure levels are linked to measurable adverse health outcomes in humans. Occupational and child‑labor reviews similarly document adverse neurological, growth, respiratory, endocrine, and biomarker changes in populations exposed to high levels of pesticides, metals, and solvents, aligning with the general notion that sufficiently high exposures to toxic chemicals can harm health.

Contradicts

The claim “Toxic chemicals” as stated is too vague and absolutist to be fully supported; toxicology is chemical‑specific, dose‑dependent, and context‑dependent. High‑quality evidence shows that only certain chemicals, at certain exposure levels and windows (e. ^[5] g. , prenatal, occupational), are clearly associated with specific health outcomes, while for many environmental contaminants the epidemiologic evidence is limited, inconsistent, or inadequate. A critical review of human exposure to environmental contaminants and congenital anomalies concluded that, as of its evaluation period, the literature was inadequate to determine whether general population exposure to environmental contaminants is or is not associated with increased risk of congenital anomalies, underscoring that broad statements about “toxic chemicals” causing anomalies lack firm support for most exposures. ^{[67][68][69][70][71]} Earlier reviews of environmental pollution and congenital anomalies similarly found that there are relatively few specific environmental pollution exposures for which strong causal conclusions about congenital anomalies can be drawn, and that evidence is often insufficient to guide precise public health and clinical practice. ^[2] Even the umbrella review that reported a pooled OR of 1. 31 for “toxic chemicals” and congenital anomalies emphasized that this association was based on a limited number of studies and that effect sizes are modest, not universal or deterministic. Major guideline‑driven areas of medicine (e. g. , hypertension management, clinical nutrition, transfusion practice) rely on graded evidence frameworks that explicitly recognize imprecision and avoid sweeping statements; guideline discussions of environmental chemicals tend to focus on specific exposures (e. ^[1][3][4][7] g. , lead, tobacco smoke) rather than undifferentiated “toxins”. Overall, the broad influencer framing implies that “toxic chemicals” as a generalized category are a dominant or universally causal threat, which is not supported by current evidence; risk is chemical‑specific, quantitatively assessed, and often uncertain or modest for many exposures.

Mainstream view

Mainstream medical and scientific positions recognize that certain chemicals are toxic and can cause or contribute to human disease, including cancers, reproductive and developmental disorders, metabolic and cardiovascular disease, neurotoxicity, and congenital anomalies, particularly at high or sustained exposure levels or during vulnerable periods such as pregnancy and early life. ^[71] However, these positions are grounded in chemical‑specific, dose‑response, and exposure‑context evidence, not in generalized claims; regulatory toxicology and environmental health typically evaluate individual substances or well‑defined classes (e. ^[70] g. , lead, mercury, specific solvents, endocrine‑disrupting chemicals, plastic‑associated chemicals) and weigh epidemiologic, toxicologic, and mechanistic data together. Mainstream reviews of environmental contaminants and congenital anomalies emphasize that, for many pollutants, the epidemiologic evidence remains limited, heterogeneous, and sometimes conflicting, and they caution against strong causal conclusions in the general population without robust, replicated data. ^{[67][5][68][69]} [ref

In their own wordsView sourceArchived copy

“Toxic chemicals”

Josselson is not licensed or approved by New Jersey Board of Naturopathic Medicine to diagnose, treat, or cure Infections.

Infections

Supports

High‑quality evidence for naturopathic or other complementary/alternative medicine (CAM) as a primary treatment for chronic ear infections (chronic otitis media with effusion or chronic suppurative otitis media) is very limited, and there are no major RCTs or meta‑analyses showing that naturopathic care can cure or definitively control chronic disease. ^[59][62] Some randomized trials in acute otitis media in children have tested naturopathic or herbal ear drops; these show that herbal/naturopathic drops can reduce ear pain similarly to conventional anesthetic drops over a few days, but these studies address acute pain management rather than chronic infection, hearing outcomes, or long‑term control. Systematic reviews of herbal medicines for otitis media with effusion and acute otitis media report some signal of symptom improvement, but overall rate the evidence as poor quality and inconclusive, with small, heterogeneous trials and high risk of bias. ^{[6][5][60][61]} A broader review of CAM options for otitis media concludes that, despite popularity, CAM therapies are not considered evidence‑based treatments in the medical community because robust, consistent clinical data are lacking. ^[1][2]

Contradicts

Up‑to‑date narrative and guideline‑style reviews of chronic suppurative otitis media emphasize that the optimal evidence‑based treatment for persistent ear discharge is topical antibiotics, with antiseptics as an alternative in resource‑limited settings, and surgery (e. ^{[1][6][59][62]} g. , tympanoplasty, mastoid surgery) for persistent disease; they do not recommend naturopathic or other CAM therapies as curative or primary treatments for chronic ear infections. These reviews highlight that chronic otitis media is a significant cause of preventable hearing loss and sometimes intracranial complications, underscoring the importance of well‑studied antimicrobial and surgical strategies rather than unproven alternatives. Systematic reviews of herbal medicines for otitis media with effusion and for acute otitis media explicitly conclude that, despite some indications of benefit, the overall evidence is of poor quality and efficacy remains inconclusive; this contradicts any strong claim that naturopathic or herbal therapies are established effective treatments for otitis media. ^[5][60][61] A review focused on CAM for pediatric otitis media notes that, among many CAM modalities, only xylitol has reasonably good trial support for prevention of acute episodes; most other CAM approaches (including herbal mixtures, homeopathy, osteopathic manipulation) either show no benefit, possible harm, or remain unproven, which again fails to support strong therapeutic claims for naturopathic management of chronic ear disease. Overall, major otology and pediatric guidelines and reviews do not list naturopathic medicine as a standard, recommended treatment for chronic otitis media; instead, they emphasize watchful waiting, appropriate antibiotics, tympanostomy tubes, and surgery as indicated, indicating that any claim of established naturopathic efficacy is not aligned with current evidence. ^[2][4]

Mainstream view

Mainstream medical and otolaryngology practice regards chronic ear infections (chronic otitis media with effusion and chronic suppurative otitis media) as conditions that should be managed with evidence‑based interventions: accurate diagnosis, risk‑factor management, topical or systemic antibiotics when indicated, tympanostomy tubes for persistent effusion with hearing loss, and surgical repair/mastoid surgery for chronic suppurative disease or cholesteatoma. ^[1][4][59] Complementary or naturopathic therapies may be used by families as adjuncts for symptom relief, but they are not considered proven disease‑modifying treatments for chronic ear infections and are not recommended as replacements for guideline‑based care. ^[3][62] Systematic reviews of herbal and other CAM therapies for otitis media consistently describe the evidence as weak, heterogeneous, and at high risk of bias, leading to the mainstream position that these modalities should, at most, be considered experimental or adjunctive, and that clinicians should counsel families about the current evidence limitations and the risks of delaying effective conventional treatment. ^{[6][5][60][61]}

In their own wordsView sourceArchived copy

“Infections”